A 62-year-old woman with type 2 diabetes (on metformin 1000 mg BD) and hypertension (on lisinopril 10 mg daily) is prescribed ibuprofen 800 mg TDS for chronic knee osteoarthritis. After 3 weeks, her serum creatinine rises from 0.9 mg/dL to 1.8 mg/dL, and potassium increases to 5.8 mEq/L. What is the primary mechanism underlying this adverse drug interaction?

Explanation

## Triple Whammy: NSAIDs, ACE Inhibitors, and Renal Function ### The "Triple Whammy" Concept **Key Point:** The combination of NSAIDs + ACE inhibitors + volume depletion (or renal disease) is known as the "triple whammy" and carries high risk of acute kidney injury (AKI) and hyperkalemia. In this case, metformin is a fourth risk factor for AKI. ### Mechanism of Renal Injury 1. **NSAID Effect:** - Inhibits COX-1 and COX-2 enzymes - Reduces renal prostaglandin (PGE~2~, PGI~2~) synthesis - Causes vasoconstriction of afferent arteriole - Decreases glomerular filtration rate (GFR) 2. **ACE Inhibitor Effect:** - Normally dilates efferent arteriole via angiotensin II blockade - Maintains glomerular filtration pressure - **When combined with NSAIDs:** Loss of compensatory efferent vasodilation - Result: Severe reduction in GFR 3. **Hyperkalemia Mechanism:** - ACE inhibitors reduce aldosterone secretion → decreased K^+^ excretion - NSAIDs further reduce renal K^+^ clearance - Declining GFR prevents K^+^ elimination - Metformin accumulation increases lactic acidosis risk (though not the primary issue here) ### Pathophysiology Flowchart ```mermaid flowchart TD A[NSAID + ACE-I combination]:::action --> B[NSAID inhibits renal PG synthesis]:::outcome B --> C[Afferent arteriole vasoconstriction]:::outcome A --> D[ACE-I blocks Ang II on efferent arteriole]:::outcome C --> E[Loss of compensatory efferent vasodilation]:::urgent D --> E E --> F[Severe GFR reduction]:::urgent F --> G[Acute Kidney Injury]:::urgent D --> H[Reduced aldosterone secretion]:::outcome H --> I[Decreased K+ excretion]:::outcome F --> I I --> J[Hyperkalemia]:::urgent ``` ### Clinical Features in This Case | Finding | Mechanism | |---|---| | Creatinine doubled (0.9 → 1.8) | Reduced GFR from afferent vasoconstriction + loss of efferent vasodilation | | Hyperkalemia (5.8 mEq/L) | Reduced aldosterone + declining GFR + ACE inhibitor effect | | Timeline (3 weeks) | Consistent with NSAID-induced AKI; slower than prerenal azotemia | ### Management **Clinical Pearl:** Discontinue the NSAID immediately. Consider: - IV hydration to restore renal perfusion - Potassium-lowering agents (calcium gluconate, insulin + glucose, sodium polystyrene sulfonate) - Monitor renal function and electrolytes daily until stable - Alternative analgesia: acetaminophen, topical NSAIDs, or selective COX-2 inhibitors (with caution) **High-Yield:** The triple whammy is a high-yield topic in NEET PG. Always ask: "Is the patient on NSAIDs + ACE-I/ARB + diuretic or renal disease?" If yes, monitor renal function closely. **Mnemonic: "NSAID + ACE-I = AKI"** — Remember that NSAIDs remove the renal-protective effect of ACE inhibitors. [cite:Harrison 21e Ch 297]